Mitchell B Berkenpas

Title: The Innovations of Mitchell B Berkenpas

Introduction

Mitchell B Berkenpas is a notable inventor based in Byron Center, MI (US). He has made significant contributions to the field of ion channel research, holding 2 patents that showcase his innovative approaches. His work primarily focuses on the alpha-7 nicotinic acetylcholine receptors, which are crucial for understanding various physiological processes.

Latest Patents

Berkenpas's latest patents include groundbreaking inventions related to measuring ion channel transmission. The first patent, titled "Double mutant alpha-7 nicotinic acetylcholine receptors," relates to novel methods for measuring ion channel transmission and methods and compositions useful in the identification of ligand-gated channel agonists and modulators. The second patent, also titled "Double mutant alpha-7 nicotinic acetylcholine receptor," focuses on innovative methods for measuring cellular ion channel transmission and identifying ligand-gated ion channel agonists and modulators.

Career Highlights

Mitchell B Berkenpas is associated with Pharmacia & Upjohn Company, where he has been able to apply his expertise in the field of pharmacology and ion channel research. His work has contributed to advancements in understanding how these receptors function and their potential therapeutic applications.

Collaborations

Throughout his career, Berkenpas has collaborated with notable colleagues, including Vincent E Groppi, Jr and Mark L Wolfe. These collaborations have further enriched his research and contributed to the development of innovative solutions in the field.

Conclusion

Mitchell B Berkenpas stands out as an influential inventor in the realm of ion channel research. His patents reflect his commitment to advancing scientific knowledge and improving methodologies in the study of nicotinic acetylcholine receptors. His contributions continue to impact the field significantly.